Addition of Vision Impairment to a Life-Course Model of Potentially Modifiable Dementia Risk Factors in the US
- PMID: 35467745
- PMCID: PMC9039828
- DOI: 10.1001/jamaneurol.2022.0723
Addition of Vision Impairment to a Life-Course Model of Potentially Modifiable Dementia Risk Factors in the US
Erratum in
-
Errors in the Text and Key Points.JAMA Neurol. 2022 Jun 1;79(6):634. doi: 10.1001/jamaneurol.2022.1557. JAMA Neurol. 2022. PMID: 35695887 Free PMC article. No abstract available.
Abstract
Importance: Dementia prevention is a high priority, given the large impact of dementia on the well-being of individuals and society. The number of older adults with dementia in the US and globally is projected to increase as a result of population aging and growth. Thus, it is vital to identify potentially modifiable dementia risk factors. Vision impairment has been identified as a risk factor for accelerated cognitive decline and incident dementia. An estimated 90% of vision impairment is preventable or has yet to be treated. Nevertheless, vision impairment has not been included in the dominant life-course models of dementia risk factors used to shape public health policy and research priorities.
Objective: To strengthen an existing model of potentially modifiable dementia risk factors through the inclusion of vision impairment and to estimate the contributions of those risk factors in the US population.
Design, setting, and participants: Population-based, cross-sectional study using data from the 2018 round of the Health and Retirement Study. Analyses were conducted from March 11 through September 24, 2021. The study population was a probability sample of US adults aged 50 years and older.
Exposures: Potentially modifiable dementia risk factors, including vision impairment.
Main outcomes and measures: The estimated population attributable fractions (PAFs) of dementia associated with vision impairment and other dementia risk factors were calculated. The PAF represents the number of cases of dementia that would potentially be prevented if a risk factor were eliminated.
Results: The probability sample from the Health and Retirement Study included 16 690 participants (weighted demographic characteristics: 54.0% female, 52.0% age ≥65, 10.6% Black, 80% White, and 9.2% identified as other [including American Indian or Alaska Native, Asian, and Hawiian Native or Pacific Islander, although specific data were not available]). The 12 dementia risk factors in the PAF model were associated with an estimated 62.4% of dementia cases in the US. The risk factor with the highest weighted PAF for dementia was hypertension (12.4%). The PAF of vision impairment was 1.8%, suggesting that more than 100 000 prevalent dementia cases in the US could potentially have been prevented through healthy vision.
Conclusions and relevance: Existing life-course models of potentially modifiable dementia risk factors may consider including vision impairment. Since a large majority of vision impairment can be treated with cost-effective but underused interventions, this may represent a viable target for future interventional research that aims to slow cognitive decline and prevent incident dementia.
Conflict of interest statement
Similar articles
-
Vision Impairment and the Population Attributable Fraction of Dementia in Older Adults.JAMA Ophthalmol. 2024 Oct 1;142(10):900-908. doi: 10.1001/jamaophthalmol.2024.3131. JAMA Ophthalmol. 2024. PMID: 39235822
-
Variation in Population Attributable Fraction of Dementia Associated With Potentially Modifiable Risk Factors by Race and Ethnicity in the US.JAMA Netw Open. 2022 Jul 1;5(7):e2219672. doi: 10.1001/jamanetworkopen.2022.19672. JAMA Netw Open. 2022. PMID: 35793088 Free PMC article.
-
Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: The 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project.JAMA Neurol. 2022 Dec 1;79(12):1242-1249. doi: 10.1001/jamaneurol.2022.3543. JAMA Neurol. 2022. PMID: 36279130 Free PMC article.
-
Multi-domain prognostic models used in middle-aged adults without known cognitive impairment for predicting subsequent dementia.Cochrane Database Syst Rev. 2023 Jun 2;6(6):CD014885. doi: 10.1002/14651858.CD014885.pub2. Cochrane Database Syst Rev. 2023. PMID: 37265424 Free PMC article. Review.
-
The Role of Vascular Risk Factors in Cognitive Impairment and Dementia and Prospects for Prevention.Clin Geriatr Med. 2023 Feb;39(1):123-134. doi: 10.1016/j.cger.2022.07.007. Epub 2022 Oct 18. Clin Geriatr Med. 2023. PMID: 36404025 Review.
Cited by
-
A comprehensive evaluation on the associations between hearing and vision impairments and risk of all-cause and cause-specific dementia: results from cohort study, meta-analysis and Mendelian randomization study.BMC Med. 2024 Nov 7;22(1):518. doi: 10.1186/s12916-024-03748-7. BMC Med. 2024. PMID: 39506811 Free PMC article.
-
Dual sensory impairments in companion dogs: Prevalence and relationship to cognitive impairment.PLoS One. 2024 Oct 16;19(10):e0310299. doi: 10.1371/journal.pone.0310299. eCollection 2024. PLoS One. 2024. PMID: 39413072 Free PMC article.
-
The Influence of Vision Impairment on the Measurement of Cognition in Older Adults in India: Findings From LASI-DAD.Innov Aging. 2024 Aug 9;8(9):igae071. doi: 10.1093/geroni/igae071. eCollection 2024. Innov Aging. 2024. PMID: 39291218 Free PMC article.
-
Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic.Alzheimers Res Ther. 2024 Aug 21;16(1):190. doi: 10.1186/s13195-024-01545-1. Alzheimers Res Ther. 2024. PMID: 39169442 Free PMC article.
-
Visual Impairment, Eye Conditions, and Diagnoses of Neurodegeneration and Dementia.JAMA Netw Open. 2024 Jul 1;7(7):e2424539. doi: 10.1001/jamanetworkopen.2024.24539. JAMA Netw Open. 2024. PMID: 39078629 Free PMC article.
References
-
- Alzheimer’s Association . 2020 Alzheimer’s disease facts and figures. Alzheimers Dement. 2020;15(3):321-387. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
